Compare Element Solutions Inc. Common Stock (ESI) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Element Solutions Inc. Common Stock vs Organon & Co. Common Stock — how do they compare? Element Solutions Inc. Common Stock trades at $35.59 (market cap $9.07B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Element Solutions Inc. Common Stock is far larger — about 2.5× Organon & Co. Common Stock's market cap, and Element Solutions Inc. Common Stock pays the higher dividend (0.86%). Which is the better fit depends on your goals — on Pluang, investors hold Element Solutions Inc. Common Stock for 6 Days and Organon & Co. Common Stock for 0 Days on average.
| ESI | OGN | |
|---|---|---|
Market Cap | $9.07B | $3.62B |
Volume | 3,090,738 | 2,892,999 |
Sector | Basic Materials | Health |
52-Week High | $49.09 | $13.81 |
52-Week Low | $22.99 | $5.70 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $11.00B | $11.04B |
Dividend Yield | 0.86% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Element Solutions (ESI) trades at $37.20, up 2.06% today, with a neutral technical signal and bullish moving averages. The company shows strong earnings momentum with three consecutive quarterly beats and robust revenue growth from $2.55B in 2025 to $3.2B projected for 2026. Recent developments include the termination of the Solstice merger and focus on AI-driven demand and operational efficiencies.
ESI presents a mixed outlook with strong fundamental growth offset by valuation concerns. The stock trades at a premium P/E of 50.27 with analyst consensus target of $47.90 suggesting 28.8% upside. Key risks include inflation pressures and uneven industrial demand, while catalysts include continued AI adoption and data center expansion driving future performance.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Element Solutions Inc. Common Stock
Element Solutions provides specialty chemical products and technical services. Its solutions support electronics, communications, automotive systems, industrial surface finishing, and offshore energy.
Read more on ESI →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
